The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient
Open accessAbstract
BACKGROUND: Neural stem cells are currently being investigated as potential therapies for neurodegenerative diseases, stroke, and trauma. However, concerns have been raised over the safety of this experimental therapeutic approach, including, for example, whether there is the potential for tumors to develop from transplanted stem cells. METHODS AND FINDINGS: A boy with ataxia telangiectasia (AT) was treated with intracerebellar and intrathecal injection of human fetal neural stem cells. Four years after the first treatment he was diagnosed with a multifocal brain tumor. The biopsied tumor was diagnosed as a glioneuronal neoplasm. We compared the tumor cells and the patient's peripheral blood cells by fluorescent in situ hybridization using X and Y chromosome probes, by PCR for the amelogenin gene X- and Y-specific alleles, by MassArray for the ATM patient specific mutation and for several SNPs, by PCR for polymorphic microsatellites, and by human leukocyte antigen (HLA) typing. Molecular and cytogenetic studies showed that the tumor was of nonhost origin suggesting it was derived from the transplanted neural stem cells. Microsatellite and HLA analysis demonstrated that the tumor is derived from at least two donors. CONCLUSIONS: This is the first report of a human brain tumor complicating neural stem cell therapy. The findings here suggest that neuronal stem/progenitor cells may be involved in gliomagenesis and provide the first example of a donor-derived brain tumor. Further work is urgently needed to assess the safety of these therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
Reubinoff, B. E., Pera, M. F., Fong, C.-Y., Trounson, A., & Bongso, A. (2000) · Nature Biotechnology · doi:10.1038/74447 · Cited by 2,706
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577 · cited 1×
“Since the patient is affected by AT, known to be characterized by genetic instability [19], we used several complementary methodologies to prove that the nonidentity of the tumor and the patient is not due to chromosomal and genetic instability.”
MethodLee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
Björklund, L. M., Sánchez-Pernaute, R., Chung, S., Andersson, T., Chen, I. Y. C., McNaught, K. S. P., Brownell, A.-L., Jenkins, B. G., Wahlestedt, C., Kim, K.-S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022438099 · Cited by 1,170
Neural progenitors from human embryonic stem cells
Reubinoff, B. E., Itsykson, P., Turetsky, T., Pera, M. F., Reinhartz, E., Itzik, A., & Ben-Hur, T. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1134 · Cited by 1,119
Neural Stem Cells and the Origin of Gliomas
Sanai, N., Alvarez-Buylla, A., & Berger, M. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043666 · Cited by 1,044
Vescovi, A. L., Galli, R., & Reynolds, B. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1889 · Cited by 990
Embryonic Stem Cell-Derived Glial Precursors: A Source of Myelinating Transplants
Brüstle, O., Jones, K. N., Learish, R. D., Karram, K., Choudhary, K., Wiestler, O. D., Duncan, I. D., & McKay, R. D. G. (1999) · Science · doi:10.1126/science.285.5428.754 · Cited by 976
Stem cell therapy for human neurodegenerative disorders–how to make it work
Lindvall, O., Kokaia, Z., & Martinez-Serrano, A. (2004) · Nature Medicine · doi:10.1038/nm1064 · Cited by 915
Stem cells for the treatment of neurological disorders
Lindvall, O., & Kokaia, Z. (2006) · Nature · doi:10.1038/nature04960 · Cited by 829
Roy, N. S., Cleren, C., Singh, S. K., Yang, L., Beal, M. F., & Goldman, S. A. (2006) · Nature Medicine · doi:10.1038/nm1495 · Cited by 821
Flax, J. D., Aurora, S., Yang, C., Simonin, C., Wills, A. M., Billinghurst, L. L., Jendoubi, M., Sidman, R. L., Wolfe, J. H., Kim, S. U., et al. (1998) · Nature Biotechnology · doi:10.1038/3473 · Cited by 770
Infection, immune responses and the aetiology of childhood leukaemia
Greaves, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1816 · Cited by 640
Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial
Kondziolka, D., Steinberg, G. K., Wechsler, L., Meltzer, C. C., Elder, E., Gebel, J., DeCesare, S., Jovin, T., Zafonte, R., Lebowitz, J., et al. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.103.1.0038 · Cited by 451
Transmission of devil facial-tumour disease
Pearse, A.-M., & Swift, K. (2006) · Nature · doi:10.1038/439549a · Cited by 414
Host-Dependent Tumorigenesis of Embryonic Stem Cell Transplantation in Experimental Stroke
Erdö, F., Bührle, C., Blunk, J., Hoehn, M., Xia, Y., Fleischmann, B., Föcking, M., Küstermann, E., Kolossov, E., Hescheler, J., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000071886.63724.fb · Cited by 355
Mismatch repair defects in human carcinogenesis
Eshleman, J. R., & Markowitz, S. D. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1489 · Cited by 223
Isacson, O., Deacon, T. W., Pakzaban, P., Galpern, W. R., Dinsmore, J., & Burns, L. H. (1995) · Nature Medicine · doi:10.1038/nm1195-1189 · Cited by 220
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance
Loebstein, R., Dvoskin, I., Halkin, H., Vecsler, M., Lubetsky, A., Rechavi, G., Amariglio, N., Cohen, Y., Ken-Dror, G., Almog, S., et al. (2007) · Blood · doi:10.1182/blood-2006-08-038984 · Cited by 171
Self-citationAdult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells
Shivraj Sohur, U., Emsley, J. G., Mitchell, B. D., & Macklis, J. D. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1887 · Cited by 170
Transplacental Transmission of Natural-Killer-Cell Lymphoma
Catlin, E. A., Roberts, J. D., Erana, R. A., Preffer, F. I., Ferry, J. A., Kelliher, A. S., Atkins, L., & Weinstein, H. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410204 · Cited by 115
Ataxia-telangiectasia: founder effect among north African Jews
Gilad, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.12.2033 · Cited by 106
Cell replacement therapy in neurological disease
Goldman, S. A., & Windrem, M. S. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.1886 · Cited by 89
Amariglio, E. N., Hakim, I., Brok‐Simoni, F., Grossman, Z., Katzir, N., Harmelin, A., Ramot, B., & Rechavi, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8136 · Cited by 39
Self-citationAstrocytoma linked to familial ataxia-telangiectasia
Miyagi, K., Mukawa, J., Kinjo, N., Horikawa, K., Mekaru, S., Nakasone, S., KOGA, H., Higa, Y., & Naito, M. (1995) · Acta Neurochirurgica · doi:10.1007/bf02307420 · Cited by 31
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
Discher, D. E., Mooney, D. J., & Zandstra, P. W. (2009) · Science · doi:10.1126/science.1171643 · Cited by 2,667
Mesenchymal Stem Cells for Regenerative Medicine
Han, Y., Li, X., Zhang, Y., Han, Y., Chang, F., & Ding, J. (2019) · Cells · doi:10.3390/cells8080886 · Cited by 1,093
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts
Caiazzo, M., Dell’Anno, M. T., Dvoretskova, E., Lazarevic, D., Taverna, S., Leo, D., Sotnikova, T. D., Menegon, A., Roncaglia, P., Colciago, G., et al. (2011) · Nature · doi:10.1038/nature10284 · Cited by 1,012
Risk factors in the development of stem cell therapy
Herberts, C. A., Kwa, M. S., & Hermsen, H. P. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-29 · Cited by 753
Metadata
- Authors
- Amariglio, N., Hirshberg, A., Scheithauer, B. W., Cohen, Y., Loewenthal, R., Trakhtenbrot, L., Paz, N., Koren-Michowitz, M., Waldman, D., Leider-Trejo, L., Toren, A., Constantini, S., & Rechavi, G.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-02-17
- Volume
- 6
- Issue
- 2
- Pages
- e1000029
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2149033728
- Cited by
- 933
- References
- 26
- FWCI
- 49.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.